Skip to content

Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers

Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01508832
Enrollment
12
Registered
2012-01-12
Start date
2012-01-31
Completion date
Unknown
Last updated
2020-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Onset and Duration of a Digital Nerve Block

Brief summary

The duration of the autonomic (sympathetic) block will last longer than the sensory block. The duration of the increased perfusion index will last longer than either the sympathetic or sensory block.

Detailed description

The Masimo SpHb™ (SpHb) is a device used to monitor the blood hemoglobin level via a sticky sensor connected to a finger. Our results from 2 recent studies undertaken with this device concluded: 1) that it is not always accurate when the finger is cold such as during surgical blood loss, and 2) a local nerve block to the finger improved the finger temperature and the accuracy of the device. Our purpose is to investigate the duration of effect of two local nerve blocking drugs (lidocaine and bupivacaine - both FDA approved drugs in routine use) in a finger on each hand. Having a better understanding of how long the nerve block lasts could help determine when an additional block might be necessary to maintain the accuracy of the device during surgical blood loss. We previously listed the primary outcome for this study as the time until return to baseline finger temperature. However, in blinded looks at the data it became clear that defining time until return to baseline from the serial temperature measurements in an objective fashion would be extremely difficult and potentially controversial. We have modified the primary outcome to be the change in the average temperature from baseline to post-intervention.

Interventions

DRUGLidocaine Digital Nerve Block

Lidocaine 1% Digital Nerve Block (2 cc

DRUGBupivacaine Digital Block

Bupivacaine 0.25% Digital Block (2 cc)

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Non-smokers

Exclusion criteria

* History of allergic response to local anesthetics * BMI \>25 * Pregnant of nursing * Current smokers or past smokers of \> 1 pack year history * Neurological deficit and/or injury in the upper extremities * Current respiratory infection * Per investigator judgement, would not be suitable for study

Design outcomes

Primary

MeasureTime frame
The Change in the Average Finger Temperature From Baseline to Post-intervention.30 minutes prior and 240 minutes post intervention.

Countries

United States

Participant flow

Recruitment details

Volunteers recruited through local media source. Protocol consisted of a single study day in anesthesia research study space at the University of California San Francisco Parnassus campus.

Participants by arm

ArmCount
Lidocaine Block, Right Finger; Bupivacaine Block, Left Finger
Lidocaine 1% Digital Nerve Block (2 cc) , right finger. Bupivacaine 0.25% Digital Nerve Block (2 cc), left finger
6
Lidocaine Block, Left Finger; Bupivacaine Block, Right Finger
Lidocaine 1% Digital Block (2cc), left finger; Bupivacaine 0.25% Digital Block (2 cc), right finger.
6
Total12

Baseline characteristics

CharacteristicLidocaine Block, Right Finger; Bupivacaine Block, Left FingerLidocaine Block, Left Finger; Bupivacaine Block, Right FingerTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
6 Participants6 Participants12 Participants
Region of Enrollment
United States
6 participants6 participants12 participants
Sex: Female, Male
Female
3 Participants3 Participants6 Participants
Sex: Female, Male
Male
3 Participants3 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
1 / 121 / 12
serious
Total, serious adverse events
0 / 120 / 12

Outcome results

Primary

The Change in the Average Finger Temperature From Baseline to Post-intervention.

Time frame: 30 minutes prior and 240 minutes post intervention.

Population: The correspondingly-treated(lidocaine, bupivacaine) finger of all 12 study participants included in analysis for each arm/group

ArmMeasureValue (MEAN)Dispersion
LidocaineThe Change in the Average Finger Temperature From Baseline to Post-intervention.-1.35 degrees centigradeStandard Error 0.71
BupivacaineThe Change in the Average Finger Temperature From Baseline to Post-intervention.0.93 degrees centigradeStandard Error 0.71

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026